Jeffrey Fryer
No más puestos en curso
Perfil
Jeffrey M.
Fryer is the founder of Rallybio LLC and Rallybio Corp.
(founded in 2018).
At Rallybio Corp., he held the title of Chief Financial Officer & Treasurer until 2023.
He previously worked at Alexion Pharmaceuticals, Inc. as Chief Tax Officer & Vice President from 2008 to 2017.
Mr. Fryer has a graduate degree from the University of Hartford and an undergraduate degree from Bryant University.
Antiguos cargos conocidos de Jeffrey Fryer.
| Empresas | Cargo | Fin |
|---|---|---|
| RALLYBIO CORPORATION | Founder | 01/02/2023 |
| ALEXION PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 01/04/2017 |
Rallybio LLC
 Rallybio LLC Miscellaneous Commercial ServicesCommercial Services Rallybio LLC operates as a development-stage biotechnology company. The firm develops transformative therapies for patients. It focuses on bringing life-transforming medicines to patients with devastating and rare disorder. The company was founded by Martin Mackay, Stephen Uden and Jeffrey Fryer in 2018 and is headquartered in Farmington, CT. | Founder | - |
Formación de Jeffrey Fryer.
| University of Hartford | Graduate Degree |
| Bryant University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| RALLYBIO CORPORATION | Health Technology |
| Empresas privadas | 2 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
Rallybio LLC
Rallybio LLC Miscellaneous Commercial ServicesCommercial Services Rallybio LLC operates as a development-stage biotechnology company. The firm develops transformative therapies for patients. It focuses on bringing life-transforming medicines to patients with devastating and rare disorder. The company was founded by Martin Mackay, Stephen Uden and Jeffrey Fryer in 2018 and is headquartered in Farmington, CT. | Commercial Services |
- Bolsa de valores
- Insiders
- Jeffrey Fryer
